SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Urology Referral — Benjamin Franklin

PatientBenjamin Franklin
Date of birth1950-01-17
IdentifiersMRN HR-EN004-SYN; SSN (made up) 000-04-3318
Document date2026-03-02
AuthorLydia Penhallow, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Bladder stone with hematuria and obstructive voiding symptoms in a 76-year-old man with gout and stage 3a chronic kidney disease. Please confirm the diagnosis, remove the stone, look for its cause and for other sources of the bleeding, and advise on preventing recurrence. [S]

Urgency: Soon, within four weeks. [S]

Questions for the consultant:

History of Present Illness

Two months of an interrupted urinary stream, pain at the end of voiding, and pink urine after car journeys. Recurrent gout, with three flares in the past year in the right big toe. Non-contrast CT today: single 2.6 cm bladder stone of about 420 Hounsfield units, no kidney stones, no hydronephrosis, enlarged prostate. Urinalysis: pH 5.2 and 12 red cells per high-power field. Serum urate 9.1 mg/dL; creatinine 1.36 mg/dL, eGFR 54; IPSS 16. Today we stopped hydrochlorothiazide, started losartan 50 mg, allopurinol 100 mg, and colchicine 0.6 mg daily, and advised acetaminophen rather than NSAIDs for pain. Never smoker. Worked with hot-metal printing type when young; blood lead 3.1 µg/dL [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrochlorothiazide 25 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2019-05-06 to 2026-03-02stoppedS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-02activeS
Allopurinol 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-02 to 2026-03-30completedS
Colchicine 0.6 mg oral tablet, one tablet by mouth daily for flare prophylaxisOne tablet by mouth dailyOral route2026-03-02 to 2026-09-14completedS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain, no more than 3 g a dayTwo tablets every 6 hours as needed; maximum 6 tablets a dayOral route2026-03-02activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Gout with recurrent flares, mostly in the right big toe, without tophi; synthetic modern diagnosis linked to his documented goutactiveconfirmed M1A.0710S — Synthetic modern diagnosis; his recurrent gout is documented in his own letters (D).
Bladder stone (2.6 cm, uric acid on analysis) with bladder outlet obstruction, removed by cystolitholapaxy; synthetic modern diagnosis linked to his documented stoneresolvedconfirmed N21.0S — Synthetic modern diagnosis confirmed by CT and cystoscopy; his stone is documented in his own letters (D), though its composition is not known.
Chronic kidney disease stage G3a A1activeconfirmed N18.31S — Synthetic diagnosis; no measure of kidney function from his lifetime exists.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis; no blood pressure from his lifetime exists.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1724Occupational exposure to heated type metal as a compositor in London, with an obscure pain in the bones of the hand; he stopped heating the typeD (CLM-0002)
February 1727 (1726/7 Old Style)Pleurisy that very nearly carried him offD (CLM-0010)
1735Severe pleurisy ending in an abscess of the left lung, with full recoveryD (CLM-0011)
October 22, 1780Gout attack at midnight, recorded in his Dialogue between Franklin and the GoutD (CLM-0005)
Winter of 1780 to 1781Long and severe fit of gout through the winter, leaving him weakenedD (CLM-0006)
About 1781First symptoms of the calculous complaint (bladder stone)D (CLM-0007)

Family History

RelativeConditionAge at deathEvidence
fatherDied in 1744 at 89; no illness before his last; cause not recorded in the cited source89D (CLM-0012)
motherDied in 1752 at 85; no illness before her last; cause not recorded in the cited source85D (CLM-0012)
natural sonDied in 1736 at four of smallpox4D (CLM-0013)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height175cmS
2026-03-02Body weight96kgS
2026-03-02Body mass index (BMI) [Ratio]31.3kg/m2S
2026-03-02Systolic blood pressure148mm[Hg]S
2026-03-02Diastolic blood pressure86mm[Hg]S
2026-03-02Heart rate74/minS
2026-03-02Respiratory rate16/minS
2026-03-02Body temperature36.7CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Urate [Mass/volume] in Serum or Plasma9.1mg/dL3.5-7.2 mg/dLHighS
2026-03-02Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-03-02Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-03-02Carbon dioxide, total [Moles/volume] in Serum or Plasma25mmol/L22-29 mmol/LNormalS
2026-03-02Urea nitrogen [Mass/volume] in Serum or Plasma22mg/dL8-23 mg/dLNormalS
2026-03-02Creatinine [Mass/volume] in Serum or Plasma1.36mg/dL0.74-1.35 mg/dLHighS
2026-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M54mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-03-02Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
2026-03-02Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-03-02Phosphate [Mass/volume] in Serum or Plasma3.4mg/dL2.5-4.5 mg/dLNormalS
2026-03-02Parathyrin.intact [Mass/volume] in Serum or Plasma52pg/mL15-65 pg/mLNormalS
2026-03-0225-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
2026-03-02Hemoglobin [Mass/volume] in Blood14.2g/dL13.2-16.6 g/dLNormalS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-03-02Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation128mg/dL<=99 mg/dLHighS
2026-03-02Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-03-02Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=30 mg/gNormalS
2026-03-02pH of Urine5.2[pH]4.5-8 [pH]NormalS
2026-03-02Erythrocytes [#/area] in Urine sediment by Microscopy high power field12/[HPF]<=2 /[HPF]HighS
2026-03-02Lead [Mass/volume] in Blood3.1ug/dL<=3.5 ug/dLNormalS
2026-03-02International Prostate Symptom Score [IPSS]16{score}S
2026-03-02Kidney failure 2-year risk [Likelihood] by KFRE0.2%S
2026-03-02Kidney failure 5-year risk [Likelihood] by KFRE0.6%S

Assessment

Plan of Treatment